Jazz Pharmaceuticals plc (JAZZ) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 10.37B |
| Enterprise Value | 14.4B |
| P/E Ratio | 69.34 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 3.38 |
| Price/Book Ratio | 3.83 |
| Enterprise/Revenue | 4.14 |
| Enterprise/EBITDA | 16.71 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.04 |
| Operating Margin | 0.2 |
| Return On Assets | 0.02 |
| Return On Equity | 0.05 |
| Revenue | 4.27B |
| Revenue/Share | 72.92 |
| Gross Profit | 3.76B |
| EBITDA | 262.76M |
| Net Income | -356.15M |
| Diluted EPS | -5.84 |
| Total Cash | 2.86B |
| Total Cash/Share | 44.15 |
| Total Debt | 5.65B |
| Total Debt/Equity | 1.35 |
| Current Ratio | 1.82 |
| Book Value Per Share | 64.79 |
| 52-Week Change | 81.05 |
| 52-Week High | 266.38 |
| 52-Week Low | 136.27 |
| Moving Average 50 Days | 229.26 |
| Moving Average 200 Days | 218.86 |
| Average Volume | 877,360 |
| Shares Outstanding | 64.19M |
| % Held by Institutions | 104.74 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |